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Pancreatic diseases, including acute and chronic pancreatitis (CP)
and pancreatic cancer, are intractable. In recent years, great
advances have beenmade in the field of pancreatology: the patho-
genesis, diagnostic modalities, and development of novel thera-
peutic interventions. This E-Book is derived from the Frontiers
in Physiology section Gastrointestinal Sciences Research Topic enti-
tled “Recent Advances in Pancreatology.” Its goal is to bring
established experts to present state-of-art studies in pancreatic
physiology, and to provide ideas on different approaches useful
to research challenges. This book presents nine contributions, in
the form of reviews, hypothesis and theory article, and original
article.
The articles can be mainly classified into three categories: pan-
creatitis, autoimmune pancreatitis (AIP), and pancreatic cancer.
To date, several pancreatitis-associated genes have been identified
such as the cationic trypsinogen (PRSS1) gene and the serine pro-
tease inhibitor, Kazal type 1 (SPINK1) gene have been identified.
The review article by Whitcomb (2012), who had originally iden-
tified the mutations in the PRSS1 gene as a cause of hereditary
pancreatitis, presented a new framework for the interpretation
of genetic variants in patients with CP based on modeling and
simulation of physiological processes with or without genetic,
metabolic, and environmental variables. This framework is espe-
cially important when we deal with billions of sequencing data
obtained by the next-generation sequencers. Ohmuraya et al.
(2012) reviewed the old and new roles of the intrapancreatic
SPINK1/Spink3 expression in the development of pancreatitis. In
addition to the established roles as a trypsin inhibitor, SPINK1
is involved in autophagy, cell growth, and cell death in pancre-
atic acinar cells and cancer cells. The precise molecular mecha-
nisms of intraductal pancreatic stone formation in CP are largely
unknown. Ko et al. (2012) reported that the mislocalization of
the cystic fibrosis transmembrane conductance regulator (CFTR)
is a cause of protein plug formation, leading to the formation
of pancreatic stones in CP. CFTR was largely mislocalized to the
cytoplasm of pancreatic duct cells in CP, including AIP. Because
corticosteroids normalized the localization of CFTR to the proper
atypical membrane, Ko et al. concluded that corticosteroidsmight
be useful to prevent protein plug and stone formation in patients
with CP.
Pancreatic stellate cells (PSCs) have attracted increasing atten-
tion from researchers. Apte et al. (2012), who originally identified
PSCs in rats, reviewed the current knowledge about the roles of
PSCs in normal and diseased pancreas. In healthy pancreas, PSCs
may maintain normal tissue architecture and act as progenitor
cells, immune cells, and an intermediary in exocrine secretion in
the pancreas. It has been established that PSCs play a critical role
in pancreatic fibrosis, a consistent histological feature of CP and
pancreatic cancer. PSCs interact closely with pancreatic cancer
cells facilitating cancer progression. Several therapeutic strategies
targeting PSCs have been examined in experimental models of CP
and pancreatic cancer, although their clinical usefulness remains
a challenge.
AIP has been increasingly recognized as a distinctive type of
pancreatitis with a presumed autoimmune etiology. The molecu-
larmechanisms responsible for the development of AIP are largely
unknown. As reviewed by Haruta et al. (2012), the induction
of AIP-like pancreatic lesions by viral and bacterial components
in mice suggests a role of commensal flora in the development
of AIP. From the clinical point of view, Kamisawa et al. (2012)
gives an overview of AIP including its concept, the international
consensus diagnostic criteria (ICDC) and standard therapeutic
regimen. The goals of the ICDC for AIP are to develop crite-
ria that can be applied worldwide, taking marked differences in
practice patterns into consideration, to safely diagnose AIP and
avoid misdiagnosis of pancreatic cancer as AIP. According to the
ICDC, AIP has been classified into two subtypes: type 1 related
with IgG4 (lymphoplasmacytic sclerosing pancreatitis) and type
2 with granulocytic epithelial lesion (idiopathic duct-centric CP).
The ICDC would contribute to further clarification of the clini-
cal features, pathogenesis, and natural history of AIP around the
world.
Lastly, three articles focus on pancreatic cancer. The epithelial-
mesenchymal transition (EMT) is a developmental process that
allows a polarized epithelial cell to undergo multiple biochemi-
cal changes that enable it to assume a mesenchymal phenotype.
The phenotype associated with EMT includes enhanced migra-
tory capacity, invasiveness, elevated resistance to apoptosis, and
greatly increased production of extracellular matrix components.
Thus, EMT plays a critical role in cancer progression. Hamada
et al. (2012) reviewed the regulators of EMT in pancreatic cancer.
In addition tomultiple cytokines, growth factors and downstream
transcriptional factors, non-coding RNA including microRNA
contributes to EMT. Satoh et al. (2012) focus onMSX2, a member
of the homeobox genes family, as an inducer of EMT in pancreatic
cancer. MSX2 enhances the malignant phenotypes of pancreatic
cancer, and evaluating MSX2 levels might be useful to differen-
tiate pancreatic cancer from CP. Mizuno et al. (2013) describe
that leucine-rich-repeat-containing G-protein-coupled receptor 5
(LRG5), a marker of intestinal stem cells, was expressed in the
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cytoplasm of pancreatic cancer cells. LRG5 was not co-localized
with CD133, a cancer stem cell marker, in either neoplastic
or non-neoplastic tissues. Further studies are required whether
LRG5 expression is useful as an indicator of the prognosis.
In summary, the articles in this E-book will contribute to
deepening our knowledge in both basic and clinical research in
the field of pancreatology. Further understanding will underpin
rational approaches to the treatment of intractable pancreatic
diseases.
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